NCT00920803 2017-06-14
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
GlaxoSmithKline
Phase 1 Completed
Clinical Trials
4 trialsNCT00433576 2014-09-15
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT00256334 2014-06-20
Resveratrol for Patients With Colon Cancer
University of California, Irvine
Phase 1 Completed
NCT00098969 2012-12-17
IRB 2004-535
National Cancer Institute (NCI)
Phase 1 Completed